Journal of General Virology, Vol 78, 2987-2999, Copyright © 1997 by Society for General Microbiology

ARTICLES

BHRF1, a viral homologue of the Bcl-2 oncogene, is conserved at both the sequence and functional level in different Epstein-Barr virus isolates

F Khanim, C Dawson, CA Meseda, J Dawson, M Mackett and LS Young
CRC Institute for Cancer Studies, The University of Birmingham Medical School, UK.

BHRF 1, a component of the restricted early antigen (EA) complex of the Epstein-Barr virus (EBV) lytic cycle, encodes a 17 kDa putative transmembrane protein with both sequence and functional homology to the Bcl-2 proto-oncogene. To determine whether there was any sequence variation over the BHRF1 open reading frame (ORF), 15 EBV isolates from different geographical regions and from both healthy donors and patients with EBV-associated diseases were sequenced. A small number of base changes which resulted in amino acid substitutions in the BHRF1 protein were found relative to the prototype B95.8 EBV sequence and these were predominantly clustered near the amino terminus of the BHRF1 protein outside conserved domains identified in the Bcl-2 homologues. In transient transfection assays none of the mutations in the BHRF1 ORF from eight different EBV isolates had a significant effect on BHRF1 protein localization compared to the B95.8 BHRF1 protein. However, transient expression of the adenovirus 12 19K protein or Bcl-2 resulted in localization patterns distinct from that observed with BHRF1 protein. Whilst all eight EBV isolates and E1B-19K gave comparable levels of protection to the DNA-damaging agent cis-platin, Bcl-2 did not afford significant protection. Thus, despite several amino acid changes in the BHRF1 ORF of some of the EBV isolates studied, the ability of the protein to protect against cis-platin induced apoptosis is conserved. The highly conserved nature of BHRF1 amongst different EBV isolates at both the sequence and functional level supports the proposed important role of BHRF1 in delaying cell death, thereby maximizing the production of progeny virus and facilitating the establishment of virus persistence.

This article has been cited by other articles:

				S. Campbell, B. Hazes, M. Kvansakul, P. Colman, and M. Barry Vaccinia Virus F1L Interacts with Bak Using Highly Divergent Bcl-2 Homology Domains and Replaces the Function of Mcl-1 J. Biol. Chem., February 12, 2010; 285(7): 4695 - 4708. [Abstract] [Full Text] [PDF]

				D. Verma, C. Ling, E. Johannsen, T. Nagaraja, and S. Swaminathan Negative Autoregulation of Epstein-Barr Virus (EBV) Replicative Gene Expression by EBV SM Protein J. Virol., August 15, 2009; 83(16): 8041 - 8050. [Abstract] [Full Text] [PDF]

				A. L. Desbien, J. W. Kappler, and P. Marrack The Epstein-Barr virus Bcl-2 homolog, BHRF1, blocks apoptosis by binding to a limited amount of Bim PNAS, April 7, 2009; 106(14): 5663 - 5668. [Abstract] [Full Text] [PDF]

				L.-Y. Li, M.-Y. Liu, H.-M. Shih, C.-H. Tsai, and J.-Y. Chen Human cellular protein VRK2 interacts specifically with Epstein-Barr virus BHRF1, a homologue of Bcl-2, and enhances cell survival. J. Gen. Virol., October 1, 2006; 87(Pt 10): 2869 - 2878. [Abstract] [Full Text] [PDF]

				P. Feng, J. Park, B.-S. Lee, S.-H. Lee, R. J. Bram, and J. U. Jung Kaposi's Sarcoma-Associated Herpesvirus Mitochondrial K7 Protein Targets a Cellular Calcium-Modulating Cyclophilin Ligand To Modulate Intracellular Calcium Concentration and Inhibit Apoptosis J. Virol., November 15, 2002; 76(22): 11491 - 11504. [Abstract] [Full Text] [PDF]

				A. Cuconati and E. White Viral homologs of BCL-2: role of apoptosis in the regulation of virus infection Genes & Dev., October 1, 2002; 16(19): 2465 - 2478. [Full Text] [PDF]

				J. M. Lee, K.-H. Lee, M. Weidner, B. A. Osborne, and S. D. Hayward Epstein-Barr virus EBNA2 blocks Nur77- mediated apoptosis PNAS, September 3, 2002; 99(18): 11878 - 11883. [Abstract] [Full Text] [PDF]

				S. Hay and G. Kannourakis A time to kill: viral manipulation of the cell death program J. Gen. Virol., June 1, 2002; 83(7): 1547 - 1564. [Abstract] [Full Text] [PDF]

				C. A. Meseda, J. R. Arrand, and M. Mackett Herpesvirus papio encodes a functional homologue of the Epstein-Barr virus apoptosis suppressor, BHRF1 J. Gen. Virol., July 1, 2000; 81(7): 1801 - 1805. [Abstract] [Full Text]

				D. S. Bellows, B. N. Chau, P. Lee, Y. Lazebnik, W. H. Burns, and J. M. Hardwick Antiapoptotic Herpesvirus Bcl-2 Homologs Escape Caspase-Mediated Conversion to Proapoptotic Proteins J. Virol., June 1, 2000; 74(11): 5024 - 5031. [Abstract] [Full Text] [PDF]

				S. Y. Hsu and A. J. W. Hsueh Tissue-Specific Bcl-2 Protein Partners in Apoptosis: An Ovarian Paradigm Physiol Rev, April 1, 2000; 80(2): 593 - 614. [Abstract] [Full Text] [PDF]

				C. W. Dawson, J. Dawson, R. Jones, K. Ward, and L. S. Young Functional Differences between BHRF1, the Epstein-Barr Virus-Encoded Bcl-2 Homologue, and Bcl-2 in Human Epithelial Cells J. Virol., November 1, 1998; 72(11): 9016 - 9024. [Abstract] [Full Text] [PDF]

				L.-Y. Li, H.-M. Shih, M.-Y. Liu, and J.-Y. Chen The Cellular Protein PRA1 Modulates the Anti-apoptotic Activity of Epstein-Barr Virus BHRF1, a Homologue of Bcl-2, through Direct Interaction J. Biol. Chem., July 13, 2001; 276(29): 27354 - 27362. [Abstract] [Full Text] [PDF]